Firm-initiated recall ongoing. Firm estimates little to no recalled product remains on the market. Label bears unapproved indication for ophthalmic use. Distributor, by letter May 2, 1991. Firm-initiated recall ongoing.
Product is an unapproved new drug.
Lot numbers 1.2.3.5 and 8.9.13. Firm-initiated recall complete. Interferon that was not approved for human use was distributed. Central Indiana Regional Blood Center, Inc., Indianapolis, Indiana. Firm-initiated recall complete.